Skip to main content

Merck Pharma to sign licensing pacts with 5 Indian drug firms for COVID-19 drug candidate molnupiravir

New Delhi: Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'molnupiravir', which is being studied for the treatment of COVID-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.

Molnupiravir is an investigational oral antiviral agent, currently being studied in a Phase 3 trial for the treatment of non-hospitalised patients with confirmed COVID-19, MSD India said in a statement.

MSD India is a wholly owned subsidiary of Merck Sharp & Dohme (MSD) and known as Merck & Co, Inc, in the United States and Canada.

MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers - Cipla, Dr Reddy's Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.

These five manufacturers have World Health Organization (WHO) Pre-Qualified Manufacturing facilities and experience as major suppliers to global and key low and middle-income countries (LMICs) procurers, MSD India said.

MSD has entered into these agreements to accelerate availability of molnupiravir in India and in other LMICs following approvals or emergency authorisation by local regulatory agencies, it added.

"These agreements, toward which we have been working as we have been studying molnupiravir, will help to accelerate access to molnupiravir in India and around the world," Merck & Co, Inc, US Chairman and CEO Kenneth C Frazier said.

"We remain committed to aiding in the global response that will bring relief to the people of India and, ultimately, bring an end to the pandemic," he added.

Under the agreements, Merck & Co, Inc, US will provide licences to these manufacturers to supply molnupiravir to India and more than 100 LMICs. The company is also in discussions with the Medicines Patent Pool to explore the potential for additional licenses, the statement said.

"Through partnerships with established Indian generics manufacturers, we are reinforcing our commitment towards expanding access to molnupiravir in India," MSD-India Region MD Rehan A Khan said.

Merck & Co, Inc will also donate more than USD 5 million worth of oxygen-production equipment, masks, hand sanitiser and financial aid to support relief efforts in India, the statement said.



from Firstpost India Latest News https://ift.tt/3aK1BVX
Labels:

Comments

Post a Comment

Popular posts from this blog

COVID-19 vaccination: Registration for citizens above 18 years of age starts today on CoWin, Aarogya Setu portals

The registration for COVID-19 vaccination for people above the age of 18 years in India started from today ( Wednesday, 28 April ). Those who are eligible for vaccination can register themselves on two applications, namely CoWin and Aarogya Setu, to book their slots for taking the vaccine jab. For those above the age of 18, coronavirus vaccination will start from 1 May. People above the age of 18 can take the following steps to register for the vaccination: Step 1 : Open the play store to download the CoWin app or visit CoWin.gov.in Step 2 : Register on the portal using your mobile number. You will receive an OTP. Enter it to complete the registration Step 3 : You will have to enter your personal details including the number of your photo identification Step 4 : After the registration, select the date, time, and venue for your COVID-19 vaccination Step 5 : Visit the vaccination centre with your appointment slip and receive your first jab Once a person receives the first jab, th...
Post a Comment
Read more

7 leopard cubs die at Bengaluru biological park after virus attack: Report

Seven leopard cubs have died at Bannerghatta Biological Park in Bengaluru after being infected by a highly contagious virus, officials said on Tuesday. Feline panleukopenia (FP) is a viral disease of cats caused by the feline parvovirus. Kittens are most severely affected by the virus, they said. The seven cubs were aged between three and eight months. All of them were vaccinated but succumbed during the course of treatment. According to officials, the first outbreak was reported on August 22. Executive Director of Bannerghatta Biological Park, AV Surya Sen said though the seven cubs were vaccinated, they were still infected. “It is now under control and in the last 15 days, no deaths have been reported. We have completely broken the chain and taken all necessary measures. We followed all the required procedure and also held discussions with all our senior veterinarians. All correct course of action was taken. Also, we have ensured hygiene of the entire zoo and the rescue centre wa...
Post a Comment
Read more

Power supply, healthcare facilities remain concern for Asia’s oldest monastery

Uninterrupted power supply and access to medical care remain important worries for Asia’s oldest monastery in Arunachal Pradesh’s Tawang. The waste left behind by the monastery’s expanding number of tourists has also become a source of concern for Abbot Shedling Tulku Thupten Tendar Rinpoche, the monastery’s chief. The Rinpoche, who has been the head of the Tawang Monastery for a year, is pleased with the monks and learners under him, but he is concerned about other facilities accessible to them. Tawang Monastery is Asia’s second largest and oldest. It was established between 1680 and 1681. Speaking to PTI in his native Tibetan through an interpreter, Rinpoche said, “The monks of our monastery are much disciplined and concentrate on their studies. They have been following the laid-down traditions well enough. “For us, one major issue is healthcare facilities. In case of any health-related emergency, our monks have to travel to Guwahati or Tezpur. If the government can ensure simil...
Post a Comment
Read more